87 results
6-K
EX-99.1
BLRX
BioLineRx Ltd.
19 Aug 24
Notice of Annual General Meeting of Shareholders
4:30pm
will be granted under and shall be subject to our Amended and Restated 2003 Share Incentive Plan (the “Plan”) and the applicable award agreements … equity-based incentive plan that may be adopted by the Company in the future, and for potential future strategic transactions (such as licensing
6-K
EX-10.1
BLRX
BioLineRx Ltd.
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
units to employees, consultants, officers or directors of the Company pursuant to any equity compensation or share incentive plan duly adopted … share option and incentive plans, the issuance of Ordinary Shares, Ordinary Share Equivalents or ADSs to employees pursuant to the Company’s employee
424B5
BLRX
BioLineRx Ltd.
1 Apr 24
Prospectus supplement for primary offering
10:30am
of outstanding options under our Amended and Restated 2003 Share Incentive Plan, or the Share Incentive Plan, at a weighted average exercise price of $0.12 per … stock units and performance stock units under our Share Incentive Plan, as of March 28, 2024;
18,683,463 ordinary shares, represented by 1,245,564 ADSs
20-F/A
2023 FY
BLRX
BioLineRx Ltd.
26 Mar 24
Annual report (foreign) (amended)
4:57pm
Incentive Plan, there are outstanding options, restricted share units and performance share units (granted to directors, employees and consultants … ) and administers our share incentive plan.
Compensation Policy
Under the Companies Law, the board of directors of a publicly traded company is required
S-8
2mfzelcv75bxn 1zsk
29 Dec 23
Registration of securities for employees
4:20pm
S-8
u4oweq zss
29 Dec 23
Registration of securities for employees
4:20pm
S-8
EX-5.1
46fs17 vt7u5
29 Dec 23
Registration of securities for employees
4:20pm
F-3
znkwtiu 6hmqhhu
29 Dec 23
Shelf registration (foreign)
4:15pm
6-K
EX-99
os13u7fh2zsq34u
30 Aug 23
Current report (foreign)
6:45am
6-K
EX-99
1dc5opwn
23 Jun 23
Notice of Annual General Meeting of Shareholders
4:16pm
6-K
EX-10.1
uifsk06n50fgm6
21 Sep 22
Current report (foreign)
8:00am
6-K
EX-99
ll2i3 bf22hhhx
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
424B5
xko1z4
3 Sep 21
Prospectus supplement for primary offering
4:29pm
6-K
EX-99
ink rsv88qsw4
26 Feb 21
Extraordinary General Meeting of Shareholders on
4:30pm
6-K
EX-99
4e077
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
424B5
v8g6e5o0b
21 Jan 21
Prospectus supplement for primary offering
4:31pm